Transgene S.A. | Balance Sheet
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,138.00
65,935.00
31,650.00
56,207.00
41,405.00
16,900
Total Accounts Receivable
11,685.00
11,074.00
14,201.00
15,740.00
14,027.00
9,238
Inventories
975.00
1,149.00
1,164.00
221.00
270.00
443
Other Current Assets
43,551.00
1,080.00
4,013.00
1,887.00
3,034.00
3,173
Total Current Assets
61,349.00
79,238.00
51,028.00
74,055.00
58,736.00
29,754
Net Property, Plant & Equipment
23,988.00
23,641.00
16,559.00
14,580.00
13,604.00
13,217
Total Investments and Advances
10,886.00
6,172.00
5,198.00
8,946.00
6,887.00
45,158
Long-Term Note Receivable
25,261.00
30,787.00
27,573.00
1,089.00
-
-
Intangible Assets
1,329.00
1,056.00
485.00
423.00
250.00
180
Other Assets
3,037.00
59.00
26.00
23,857.00
21,396.00
20,234
Total Assets
125,850.00
140,953.00
100,869.00
122,950.00
100,873.00
108,543
ST Debt & Current Portion LT Debt
959.00
1,098.00
1,153.00
1,136.00
1,101.00
Accounts Payable
9,364.00
8,296.00
6,521.00
4,504.00
2,868.00
Other Current Liabilities
13,673.00
12,169.00
19,051.00
14,279.00
12,897.00
Total Current Liabilities
23,996.00
21,563.00
26,725.00
19,919.00
16,866.00
Long-Term Debt
10,347.00
9,591.00
8,496.00
17,687.00
17,349.00
Provision for Risks & Charges
4,444.00
4,352.00
3,196.00
3,725.00
3,710.00
Other Liabilities
16,639.00
18,284.00
19,061.00
17,830.00
15,374.00
Total Liabilities
55,426.00
53,790.00
57,478.00
59,161.00
53,299.00
Common Equity (Total)
56,622.00
71,839.00
26,547.00
46,503.00
28,089.00
Total Shareholders' Equity
56,622.00
71,839.00
26,547.00
46,503.00
28,089.00
Total Equity
56,622.00
71,839.00
26,547.00
46,503.00
28,089.00
Liabilities & Shareholders' Equity
125,850.00
140,953.00
100,869.00
122,950.00
100,873.00
Non-Equity Reserves
13,802.00
15,324.00
16,844.00
17,286.00
19,485.00
About Transgene
View Profile
